Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 85.55 USD 0.14% Market Closed
Market Cap: 4.3B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Balance Sheet

Balance Sheet Decomposition
Haemonetics Corp

Current Assets 955.9m
Cash & Short-Term Investments 299.3m
Receivables 213.5m
Other Current Assets 443.1m
Non-Current Assets 1.6B
PP&E 300.5m
Intangibles 1.1B
Other Non-Current Assets 164.8m
Current Liabilities 273.9m
Accounts Payable 69.2m
Accrued Liabilities 49.3m
Other Current Liabilities 155.4m
Non-Current Liabilities 1.4B
Long-Term Debt 1.2B
Other Non-Current Liabilities 152.9m

Balance Sheet
Haemonetics Corp

Rotate your device to view
Balance Sheet
Currency: USD
Mar-2015 Apr-2016 Apr-2017 Mar-2018 Mar-2019 Mar-2020 Apr-2021 Apr-2022 Apr-2023 Mar-2024
Assets
Cash & Cash Equivalents
161
115
140
180
169
137
192
260
285
179
Cash Equivalents
161
115
140
180
169
137
192
260
285
179
Total Receivables
146
157
153
151
185
165
128
159
179
207
Accounts Receivables
146
157
153
151
185
165
128
159
179
207
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
211
187
177
161
194
270
323
293
259
317
Other Current Assets
40
29
41
29
27
31
51
44
47
66
Total Current Assets
558
488
510
521
576
604
694
756
770
769
PP&E Net
322
338
324
332
344
306
277
311
364
367
PP&E Gross
322
338
324
332
344
0
277
311
364
367
Accumulated Depreciation
410
449
484
541
589
0
600
611
633
648
Intangible Assets
245
205
178
157
128
133
366
310
276
406
Goodwill
334
268
211
211
211
211
466
467
466
565
Other Long-Term Assets
27
21
16
16
16
14
17
15
59
89
Other Assets
334
268
211
211
211
211
466
467
466
565
Total Assets
1 485
N/A
1 319
-11%
1 239
-6%
1 237
0%
1 275
+3%
1 267
-1%
1 820
+44%
1 860
+2%
1 935
+4%
2 196
+13%
Liabilities
Accounts Payable
48
40
43
55
63
51
50
58
64
73
Accrued Liabilities
59
41
52
78
66
57
79
66
72
89
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
22
44
61
194
28
77
17
214
12
10
Other Current Liabilities
60
61
55
57
79
90
107
104
105
128
Total Current Liabilities
189
186
211
385
236
275
254
442
252
300
Long-Term Debt
406
365
254
59
323
306
691
559
754
798
Deferred Income Tax
33
21
12
7
20
11
44
29
36
63
Other Liabilities
32
26
22
34
29
89
100
80
75
75
Total Liabilities
659
N/A
598
-9%
499
-16%
485
-3%
607
+25%
680
+12%
1 088
+60%
1 110
+2%
1 117
+1%
1 236
+11%
Equity
Common Stock
1
1
1
1
1
1
1
1
1
1
Retained Earnings
420
316
290
267
161
79
158
202
253
360
Additional Paid In Capital
427
440
482
504
536
553
603
573
595
635
Other Equity
22
35
33
19
30
45
30
26
30
36
Total Equity
826
N/A
722
-13%
740
+2%
752
+2%
668
-11%
587
-12%
732
+25%
749
+2%
818
+9%
960
+17%
Total Liabilities & Equity
1 485
N/A
1 319
-11%
1 239
-6%
1 237
0%
1 275
+3%
1 267
-1%
1 820
+44%
1 860
+2%
1 935
+4%
2 196
+13%
Shares Outstanding
Common Shares Outstanding
52
51
52
52
51
50
51
51
50
51

See Also

Discover More